Clinical Trials Logo

Clinical Trial Summary

The purpose of the study was to determine the efficacy of intralesional bleomycin in comparison to cryotherapy on participants having cutaneous warts.


Clinical Trial Description

This study was conducted in the Department of Dermatology of Jinnah Postgraduate Medical Centre, Karachi from January to June 2021 after receiving approval from the institutional ethical and research committee of hospital. Sample size was calculated through NCSS software. Total of one fifty four non-admitted patients were assigned two study groups with equal sample size of 77 randomly through lottery method. Those patients aged between 18 to 60 years of either gender with cutaneous warts for > 1 week to 48 weeks were included after written informed consent. Patients treated previously for warts by any methodology, with history of vascular disease, immunocompromised, hypertension, cardiovascular disorder, pregnancy, lactation and hypersensitivity to lidocaine were excluded. All demography, clinical history was recorded by a principal investigator on a predesigned Performa , informed written consent was taken before enrolment. Group A received intralesional bleomycin 0.1% therapy until the lesion blanched. It was prepared manually by diluting 15 mg powder in 5 ml distilled water and then each ml was further diluted by adding 2ml of 2% lignocaine, double the amount taken from the vial, so that concentration became 1mg/1ml (0.1%). Group B patients were treated with liquid nitrogen with the help of a cotton swab wrapped on a wooden stick and was applied firmly with 01 mm extra healthy skin margin until the lesion blanched. Follow-up was carried out at 02, 04 and 06 weeks. Both the groups were assessed and compared for efficacy after 6 weeks of therapy. SPSS 23 was used for analyzing data. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05023408
Study type Interventional
Source Jinnah Postgraduate Medical Centre
Contact
Status Completed
Phase Phase 2
Start date January 1, 2021
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT05739786 - Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase 1
Completed NCT02106260 - First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts Phase 1/Phase 2
Recruiting NCT00644579 - bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients Phase 2
Completed NCT03846648 - CyPep-1 in Cutaneous Warts Phase 1
Not yet recruiting NCT05902624 - Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts Early Phase 1
Completed NCT02333643 - A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. Phase 2
Completed NCT05862441 - A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts Phase 2/Phase 3
Completed NCT03734003 - Infrared Bioeffect System for the Treatment of Cutaneous Warts N/A